SCHEMBL4846246

SCHEMBL4846246

Cc1ccccc1-c1ccc(OCCCCCNCC(C)(C)C)c(C=O)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.42
KDM4E B2RXH2 7/20 0.41
KMT2A Q03164 2/20 0.41
MAPT P10636 2/20 0.41
MEN1 O00255 1/20 0.41
GAA P10253 2/20 0.37
PTPN11 Q06124 1/20 0.37
HSD17B10 Q99714 2/20 0.37
CYP1A2 P05177 1/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2D6 P10635 1/20 0.37
ALOX15 P16050 1/20 0.37
TSHR P16473 1/20 0.37
MAPK1 P28482 1/20 0.37
CYP2C19 P33261 1/20 0.37
CLK4 Q9HAZ1 1/20 0.37
DRD2 P14416 1/20 0.35
DRD4 P21917 1/20 0.35
SLC6A9 P48067 1/20 0.35
SCN8A Q9UQD0 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4854976 0.85 CYP1A2 (0.47) ALDH1A1KDM4EKMT2AMAPTMEN1
SCHEMBL4846256 0.80 SLC6A9 (0.41) ALDH1A1KDM4EKMT2AMAPTMEN1
SCHEMBL4852357 0.79 SLC6A9 (0.42) ALDH1A1KDM4EKMT2AMAPTMEN1
SCHEMBL4855017 0.78 KDM4E (0.49) ALDH1A1KDM4EKMT2AMAPTMEN1
SCHEMBL4852186 0.77 SLC6A9 (0.46) ALDH1A1KDM4EKMT2AMAPTMEN1
SCHEMBL4849739 0.76 ALDH1A1 (0.46) ALDH1A1KDM4EKMT2AMAPTMEN1
SCHEMBL4851155 0.76 SLC6A9 (0.46) ALDH1A1KDM4EKMT2AMAPTMEN1
SCHEMBL4856576 0.76 CYP2D6 (0.52) ALDH1A1KDM4EKMT2AMEN1CYP1A2
SCHEMBL7936530 0.76 ERN1 (0.51) ALDH1A1KDM4EKMT2AMAPTMEN1
SCHEMBL4845580 0.76 SLC6A9 (0.49) ALDH1A1KDM4EKMT2AMAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7423181-B2 in particular against bacterial and parasitic infections, fungi, and helminths; improved metabolic and physiochemical properties, bioavailability, solubility; 3-[4-(2-Dimethylamino-ethoxy)-2'-trifluoromethyl-biphenyl-3-yl]-1-(2-dimethylaminomethyl-phenyl)-propenone LICA PHARMACEUTICALS A/S (DK) 2008-09-09 US disclosed
US-20050227990-A1 Aminoalkoxy-functional chalcones LICA PHARMACEUTICALS A/S (DK) 2005-10-13 US disclosed
EP-1515940-A2 AMINOALKOXY-FUNCTIONAL CHALCONES Lica Pharmaceuticals A/S (DK) 2005-03-23 EP disclosed
WO-2003097574-A2 AMINOALKOXY-FUNCTIONAL CHALCONES LICA PHARMACEUTICALS A/S (DK) 2003-11-27 WO disclosed